{"blog": [], "keywords": [{"value": "Takeda Pharmaceutical", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Liability for Products", "name": "subject", "rank": "2", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "Bladder Cancer", "name": "subject", "rank": "4", "is_major": "Y"}, {"value": "Diabetes", "name": "subject", "rank": "5", "is_major": "Y"}, {"value": "Suits and Litigation (Civil)", "name": "subject", "rank": "6", "is_major": "N"}], "web_url": "http://www.nytimes.com/2015/04/29/business/takeda-agrees-to-pay-2-4-billion-to-settle-suits-over-cancer-risk-of-actos.html", "document_type": "article", "byline": {"person": [{"lastname": "POLLACK", "firstname": "Andrew", "role": "reported", "organization": "", "rank": 1}], "original": "By ANDREW POLLACK"}, "type_of_material": "News", "multimedia": [{"url": "images/2015/04/29/business/29DRUG/29DRUG-thumbWide.jpg", "legacy": {"wide": "images/2015/04/29/business/29DRUG/29DRUG-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2015/04/29/business/29DRUG/29DRUG-articleLarge.jpg", "legacy": {"xlarge": "images/2015/04/29/business/29DRUG/29DRUG-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2015/04/29/business/29DRUG/29DRUG-thumbStandard.jpg", "legacy": {"thumbnail": "images/2015/04/29/business/29DRUG/29DRUG-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "656", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Nearly 9,000 bladder cancer claims are pending against Takeda, which was accused of concealing the cancer risk of the big-selling medication.", "pub_date": "2015-04-29T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Takeda to Pay $2.4 Billion to Settle Suits Over Drug\u2019s Cancer Risk", "main": "Takeda Agrees to Pay $2.4 Billion to Settle Suits Over Cancer Risk of Actos"}, "print_page": "2", "snippet": "Nearly 9,000 bladder cancer claims are pending against Takeda, which was accused of concealing the cancer risk of the big-selling medication.", "_id": "55400dfd38f0d877377da13e", "slideshow_credits": null, "abstract": "Takeda Pharmaceutical will pay $2.4 billion to settle thousands of lawsuits contending that company's Actos diabetes drug caused bladder cancer; roughly 9,000 bladder cancer claims are pending against company."}